Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction.
Zheng Y, Yang W, Jia Y, Ji J, Wu L, Feng J, Li Y, Cheng Z, Zhang J, Li J, Dai W, Xu X, Wu J, Zhou Y, Guo C.
Zheng Y, et al. Among authors: zhang j.
Front Pharmacol. 2023 Feb 7;14:1081980. doi: 10.3389/fphar.2023.1081980. eCollection 2023.
Front Pharmacol. 2023.
PMID: 36843944
Free PMC article.